Delivery Order SPE2DR25D9238-SPE2DR26FRRN2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,227.04 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed-price pricing with no set-aside designation. This award represents one of numerous delivery orders issued to DMS Pharmaceutical Group under the agency's...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $50,363.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX 1 dose vials. The delivery order, awarded on January 14, 2026, with an ultimate completion date of February 5, 2026, carries no set-aside designation, indicating the contractor competed in unrestricted federal procurement. This award was issued under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of July 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract is structured as a firm fixed-price delivery order, reflecting the established pricing for this specific pharmaceutical product within the...
- The Defense Logistics Agency awarded a $55,671 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on August 4, 2025, with an ultimate completion date of August 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency awarded a delivery order valued at $11,134.20 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of May 23, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The contract utilizes firm fixed-price pricing and represents a delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,567.10 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of November 4, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a firm fixed-price contract type, with performance to be completed at the awardee's Park Ridge facility. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,660.29 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was issued without a set-aside designation to the woman-owned small business, which is based in Park Ridge, Illinois and will perform the work at its primary location. DMS Pharmaceutical Group was selected as the awardee under its existing indefinite delivery contract with...
- The Defense Logistics Agency issued a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX 1 dose vials. Valued at $1,259.08, this delivery order was awarded on January 6, 2026, with an ultimate completion date of January 28, 2026. The contract carries no set-aside designation, indicating the award was made through full and open competition. DMS Pharmaceutical Group will...
- The Defense Logistics Agency awarded a delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 4, 2025. The award was announced on July 14, 2025, under a firm fixed-price contract type with no set-aside designation. Performance will take place in Park Ridge, Illinois, where the woman-owned small business contractor is based. DMS Pharmaceutical Group Inc. is a long-established pharmaceutical wholesaler registered in...
- The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) one-dose vials on December 17, 2025, with an ultimate completion date of January 9, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order represents a routine procurement action...
- SPE2DR25D9238Indefinite Delivery Contract
- SPE2DR25D9238-SPE2DR26FRRN2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,259.08 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials on January 22, 2026, with an ultimate completion date of February 12, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract structure with no set-aside designation. The delivery order is issued under the company's single-award Indefinite Delivery Contract (SPE2DR) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three 30-month option periods. Under this master contract vehicle, the Defense Logistics Agency issues firm fixed-price delivery orders for branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and medical consumables to support military medical operations globally. DMS Pharmaceutical Group's established performance across numerous delivery orders and its comprehensive product portfolio, which includes vaccines such as YF-VAX alongside specialty pharmaceuticals and emergency medications, demonstrates its capability as a critical supplier within the federal military pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/21/26 |